Chlorella for Immune Function

Verdict: Weak, surrogate-only evidence for immune support

Chlorella may nudge a few laboratory markers of immune activity, but the evidence is weak and preliminary, and there is no proof it actually helps you get sick less often or recover faster. Treat any "immune-boosting" marketing with caution.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is C (weak evidence) because the entire human case rests on four small randomized trials, none larger than 124 participants, and almost all of them measured surrogate immune markers rather than real-world outcomes. An 8-week trial of 5 g/day raised natural-killer-cell activity and the cytokines IFN-gamma and IL-1beta (PMID 22849818), while two small trials reported higher salivary secretory IgA, a marker of mucosal immunity (PMID 28825174; PMID 21906314). These signals are directionally consistent, which keeps the grade above 'no evidence,' but the trials were rated low quality, several used multi-ingredient 'chlorella-derived' products, and none tracked infections or illness duration.

The single trial with a clinically meaningful endpoint undercuts the optimistic reading. In 124 adults given chlorella before an influenza vaccine, there was no significant improvement in antibody response in the overall group; only a small, after-the-fact subgroup aged 50-55 showed a signal, which is hypothesis-generating at best (PMID 12874157). No immune-function-specific systematic review or meta-analysis exists, so the body of evidence stays small and inconsistent rather than confirmatory.

Major authorities offer no endorsement. The NIH Office of Dietary Supplements is cautious, while Mayo Clinic, Cleveland Clinic and Harvard Health do not address chlorella for immunity at all; EFSA has rejected related health claims and the FDA treats unproven 'detox'/chelation claims as having no proof of effectiveness. Chlorella is also high in vitamin K and can interfere with the blood thinner warfarin, so people on that medication or on immunosuppressants should check with a clinician first.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
77%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L5 Clinical bodiesAuthoritative stance
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Beneficial immunostimulatory effect of short-term Chlorella supplementation: enhancement of natural killer cell activity and early inflammatory response (randomized, double-blinded, placebo-control…
PMID: 22849818 2012 RCT (double-blind) n = 51
Finding: NK cell activity increased significantly in the Chlorella group (n=23) but not placebo (n=28); serum IFN-γ (p<0.05) and IL-1β (p<0.001) rose significantly, IL-12 trended upward (p<0.1). Change in NK activity correlated with IL-1β (r=0.280, p=0.047) and IFN-γ.
🟠 Limited quality Government Effect size: Significant within/between-group increase in NK cytotoxicity; small sample, surrogate immune markers only
View on PubMed
Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial
PMID: 12874157 2003 RCT (double-blind) n = 124
Finding: No significant effect on antibody response to influenza vaccine in the overall population (≥4-fold rise: 200 mg group, placebo, 400 mg group all p>0.05). A post-hoc subgroup aged 50-55 receiving 400 mg showed significantly higher titers against some strains. Fatigue more frequent in the 200 mg group (44%) than 400 mg (20%) or placebo (19%).
Government Effect size: Null for primary endpoint; isolated positive subgroup signal only
View on PubMed
The effect of Chlorella pyrenoidosa supplementation on immune responses to 2 days of intensified training
PMID: 28825174 2018 隨機對照試驗 n = 26
Finding: Resting sIgA secretion rate increased with Chlorella (trial × time p=0.016) at weeks 4, 5 and 6 (p=0.020, <0.001, 0.016) with no change in placebo (n=13 per arm). Effect on training-induced immune perturbation was limited.
🟠 Limited quality Effect size: Significant rise in mucosal sIgA surrogate; very small sample, athletic population
View on PubMed
Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study
PMID: 21906314 2011 隨機對照試驗 n = 15
Finding: Salivary SIgA concentration and secretion rate increased significantly after chlorella intake versus baseline, with no change after placebo. All-male sample (n=15).
🟠 Limited quality Effect size: Significant within-group rise in mucosal SIgA surrogate; very small pilot, multicomponent product
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Consumers who use OTC chelation products for detoxification are exposed to all the risks associated with chelation. These risks are not acceptable, given that there is no proof that 'detoxification' using these products is effective to prevent or treat any condition or disease. source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
綠藻(小球藻)產品應符合衛福部「可供食用藻類衛生標準」,並就重金屬(砷、鉛、鎘、汞)、微囊藻毒素、神經毒素(BMAA)、農藥、塑化劑及微生物等項目進行檢驗。 source↗
L5a NIH Office of Dietary Supplements
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-immune-function-INT-chlorella-001 繁體中文版 →